Largest biotech companies by revenue
Everything the company sold in its latest fiscal year, before any cost is taken off.
Amgen leads the 21 biotech companies ranked by revenue, at DKK 250.2B, ahead of Gilead Sciences (DKK 200.5B) and Biogen (DKK 67.3B). Figures as of 18 Nov 2026, 18:41 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 21
- First
- AmgenDKK 250.2B
- Median
- DKK 8.3B
- Combined market value
- DKK 5.72T
- Countries
- 5
- Not ranked
- 3no revenue on file
Market values as of .
All countries▾
All sectors▾
Biotech▾
| # | Company | Revenue ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | AmgenAMGN · Health Care | DKK 250.2B | DKK 1.64T | DKK 3,039.20 | 2.52% down | 34% up | ||
| 2 | Gilead SciencesGILD · Health Care | DKK 200.5B | DKK 1.43T | DKK 1,150.69 | 0.73% down | 33% up | ||
| 3 | BiogenBIIB · Health Care | DKK 67.3B | DKK 253.7B | DKK 1,716.47 | 0.53% up | 49% up | ||
| 4 | argenxARGX · Health Care | DKK 28.3B | DKK 405.4B | DKK 6,447.11 | 0.06% down | 4% up | ||
| 5 | BioNTechBNTX · Health Care | DKK 21.7B | DKK 141.6B | DKK 571.16 | 1.14% down | 16% down | ||
| 6 | Neurocrine BiosciencesNBIX · Health Care | DKK 19.5B | DKK 113B | DKK 1,116.37 | 1.18% down | 20% up | ||
| 7 | ExelixisEXEL · Health Care | DKK 15.8B | DKK 114.7B | DKK 469.91 | 0.76% up | 63% up | ||
| 8 | QiagenQGEN · Health Care | DKK 14.2B | DKK 69.9B | DKK 338.38 | 0.10% down | 12% up | ||
| 9 | ModernaMRNA · Health Care | DKK 13.2B | DKK 550.2B | DKK 1,359.88 | 3.42% down | 755% up | ||
| 10 | Halozyme TherapeuticsHALO · Health Care | DKK 9.5B | DKK 74.8B | DKK 655.99 | 0.40% up | 37% up | ||
| 11 | Bio-TechneTECH · Health Care | DKK 8.3B | DKK 77.9B | DKK 495.69 | 0.24% up | 26% up | ||
| 12 | RepligenRGEN · Health Care | DKK 5B | DKK 75.5B | DKK 1,180.58 | 6.92% up | 5% up | ||
| 13 | Krystal BiotechKRYS · Health Care | DKK 2.6B | DKK 63.6B | DKK 2,146.82 | 5.62% up | 46% up | ||
| 14 | Twist BioscienceTWST · Health Care | DKK 2.6B | DKK 55B | DKK 806.18 | 5.72% up | 340% up | ||
| 15 | Adaptive BiotechnologiesADPT · Health Care | DKK 1.9B | DKK 31.7B | DKK 196.05 | 1.07% up | 88% up | ||
| 16 | ImmunityBioIBRX · Health Care | DKK 771.3M | DKK 48.6B | DKK 45.72 | 7.27% up | 193% up | ||
| 17 | Kymera TherapeuticsKYMR · Health Care | DKK 267M | DKK 71B | DKK 831.31 | 0.48% up | 87% up | ||
| 18 | CG OncologyCGON · Health Care | DKK 27.5M | DKK 48.8B | DKK 546.24 | 1.63% up | 85% up | ||
| 19 | CRISPR TherapeuticsCRSP · Health Care | DKK 23.9M | DKK 27.4B | DKK 282.24 | 3.25% up | 21% down | ||
| 20 | Revolution MedicinesRVMD · Health Care | DKK 0 | DKK 236.5B | DKK 1,093.22 | 1.30% down | 131% up | ||
| 21 | Scholar Rock HoldingSRRK · Health Care | DKK 0 | DKK 39.5B | DKK 323.88 | 5.52% up | 14% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Revenue is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 6.8084 DKK). 3 companies have no revenue on file and are not ranked here.
Questions and answers
Which biotech companies rank first by revenue?
Amgen (DKK 250.2B), Gilead Sciences (DKK 200.5B) and Biogen (DKK 67.3B) are the top three of the 21 biotech companies ranked by revenue as of 18 Nov 2026, 18:41 UTC.
How many biotech companies are in this ranking?
21 are ranked by revenue. 3 more have no revenue on file and are left out rather than ranked at zero.
What are these biotech companies worth together?
The 21 biotech companies ranked by revenue have a combined market value of DKK 5.72T as of 18 Nov 2026, 18:41 UTC.
What does ranking by revenue measure?
Everything the company sold in its latest fiscal year, before any cost is taken off.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest biotech companies by revenue”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=revenue
Underlying data: Yahoo Finance; SEC EDGAR.